Back
Kymera Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
47
KYMR
Kymera Therapeutics
Last Price:
42.13
Seasonality Move:
17.88%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.35 | Sell |
| 20-day SMA: | 44.79 | Sell |
| 50-day SMA: | 46.11 | Sell |
| 200-day SMA: | 41.35 | Buy |
| 8-day EMA: | 44.07 | Sell |
| 20-day EMA: | 45.15 | Sell |
| 50-day EMA: | 45.78 | Sell |
| 200-day EMA: | 41.1 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.87 | Sell |
| Relative Strength Index (14 RSI): | 40.12 | Sell |
| Chaikin Money Flow: | 59591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.06 - 48.4) | Sell |
| Bollinger Bands (100): | (43.26 - 48.72) | Sell |
Kymera Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 42.13 while KYMR 8-day simple moving average is 44.35, which is a Sell signal.
- The stock price of KYMR is 42.13 while Kymera Therapeutics 20-day SMA is 44.79, which makes it a Sell.
- Kymera Therapeutics 50-day simple moving average is 46.11 while KYMR share price is 42.13, making it a Sell technically.
- KYMR stock price is 42.13 and Kymera Therapeutics 200-day simple moving average is 41.35, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Sell
47
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Sell
The current Kymera Therapeutics [KYMR] share price is $42.13. The Score for KYMR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
2.73B
Price in USD:
42.13
Share Volume:
425.36K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
22.35
Sell
47
Kymera Therapeutics (KYMR)
is a Sell
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 42.13 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 42.13 while KYMR 8-day exponential moving average is 44.07, which is a Sell signal.
- The stock price of KYMR is 42.13 while Kymera Therapeutics 20-day EMA is 45.15, which makes it a Sell.
- Kymera Therapeutics 50-day exponential moving average is 45.78 while KYMR share price is 42.13, making it a Sell technically.
- KYMR stock price is 42.13 and Kymera Therapeutics 200-day simple moving average is 41.10, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is -0.87, suggesting Kymera Therapeutics is a Sell
- Kymera Therapeutics Relative Strength Index (RSI) is 40.12, which suggest Kymera Therapeutics is oversold
- The Bollinger Bands (25) for Kymera Therapeutics is (43.06 - 48.4), which suggest Kymera Therapeutics is a Sell
- The Bollinger Bands (100) for Kymera Therapeutics is (43.26 - 48.72), which suggest Kymera Therapeutics is a Sell
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.